Castle Biosciences Inc’s recent filing unveils that its Pres. & Chief Exec. Officer MAETZOLD DEREK J unloaded Company’s shares for reported $92857.0 on Jun 03 ’24. In the deal valued at $23.40 per share,3,968 shares were sold. As a result of this transaction, MAETZOLD DEREK J now holds 8,525 shares worth roughly $0.18 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, MAETZOLD DEREK J sold 2,368 shares, generating $55,416 in total proceeds. Upon selling the shares at $23.40, the Pres. & Chief Exec. Officer now owns 57,893 shares.
Before that, MAETZOLD DEREK J sold 3,968 shares. Castle Biosciences Inc shares valued at $96,290 were divested by the Pres. & Chief Exec. Officer at a price of $24.27 per share. As a result of the transaction, MAETZOLD DEREK J now holds 8,911 shares, worth roughly $0.19 million.
Guggenheim initiated its Castle Biosciences Inc [CSTL] rating to a Buy in a research note published on December 14, 2023; the price target was $25. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in early January with a ‘”a Sector outperform”‘ rating. Stephens began covering CSTL with “an Overweight” recommendation on January 07, 2022. Lake Street started covering the stock on April 30, 2021. It rated CSTL as “a Buy”.
Price Performance Review of CSTL
On Tuesday, Castle Biosciences Inc [NASDAQ:CSTL] saw its stock jump 0.33% to $21.26. Over the last five days, the stock has lost -0.84%. Castle Biosciences Inc shares have fallen nearly -1.48% since the year began. Nevertheless, the stocks have risen 54.96% over the past one year. While a 52-week high of $25.91 was reached on 05/03/24, a 52-week low of $12.07 was recorded on 02/29/24. SMA at 50 days reached $22.78, while 200 days put it at $20.33. A total of 0.2 million shares were traded, compared to the trading of 0.64 million shares in the previous session.
Levels Of Support And Resistance For CSTL Stock
The 24-hour chart illustrates a support level at 20.83, which if violated will result in even more drops to 20.40. On the upside, there is a resistance level at 21.72. A further resistance level may holdings at 22.18. The Relative Strength Index (RSI) on the 14-day chart is 42.16, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.48, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 84.37%. Stochastics%K at 20.21% indicates the stock is a holding.
The most recent change occurred on November 10, 2020 when KeyBanc Capital Markets began covering the stock and recommended ‘”an Overweight”‘ rating along with a $70 price target.
